Prolotherapy

Prolotherapy uses a solution of dextrose, lidocaine and occasionally includes growth hormone, testosterone, phenol, glycerin, or sodium morrhuate to increase its effectiveness. The solution, known as the proliferant, is injected into damaged tissues triggering a local immune cell proliferation and cascade. This influx of immune cell activity, a local inflammation, results in the rescaffolding of damaged tissues, restoring their stability, strength, and function. In many ways prolotherapy shares similar behavioural traits with its cousin platelet rich plasma (PRP) therapy, as prolotherapy also causes the release of a number of growth factors locally in the body, helping amplify its tissue rescaffolding effect. Aside from surgery there is really no way to regenerate structural integrity in ligaments, tendons, and joints that have become loose due to acute strain or longstanding injury. Over a certain degree of strain (in certain tissues as little as 4 to 6 per cent) the body does not have the tools to regenerate the tensegrity these tissues once enjoyed. The result: chronic pain and structural compensation. Ultimately, other tissues inadequately fill the role of the damaged tissues, which reveals itself as bone misalignment, muscle pain, and further instability. Prolotherapy fills this therapeutic void for those suffering from injuries that may not be an ideal candidate for surgery or are seeking a less invasive alternative. Prolotherapy rehabilitates all sorts of injuries of the joints, tendons, ligaments, and fascia getting you back in action quickly and sustainably.